CDRH Blue Book Memo Aims To Improve Use Of Pre-IDE Program

FDA's Pre-IDE Program is intended to provide sponsors with informal input that is "not in any way binding on the agency or the sponsor," FDA Office of Device Evaluation Deputy Director for Science and Regulatory Policy Phil Phillips explains in a memorandum recently sent to ODE staffers.

More from Archive

More from Medtech Insight